Chris Slootweg (UvA) has been awarded an IXAnext Physics2Market grant for his work to use sodium borohydride as a carrier of hydrogen. For his expertise on the energy transition, especially in the field of hydrogen Slootweg has been invited to participate in the round-table discussion on the energy transition. Regeneration protocol to release hydrogen Hydrogen […]
NewsVarious projects within the Amsterdam knowledge institutions have received funding through a Take-off program from NWO. With this funding, they can further investigate the market opportunities for their products through a feasibility study or with an early stage route. Projects Feasibility studies (phase 1) VU-AMS, Ambulatory Monitoring of the Autonomic Nervous System Hoofdaanvrager: Prof. dr. […]
NewsLUMICKS has entered into a collaboration with Glycostem Therapeutics, the Netherlands, to improve immunotherapeutic drug development. By quantifying binding strength between immune and cancer cells using the unique z-Movi® Cell Avidity Analyzer, Glycostem exploits the predictiveness of avidity in finding the best NK-cell population for cellular therapy. Glycostem is a leading NK-cell manufacturer that has […]
NewsCimCure, a spin-off of Amsterdam UMC and focusing on cancer immunotherapies for solid tumors, signed a strategic partnership agreement for in-licensing CimCure’s iBoost technology with Intravacc, a worldwide leading translational research and development vaccine organization with an extensive track record in developing viral and bacterial vaccines. The iBoost (immune boost) technology was developed at Amsterdam […]
NewsAn annual survey held by the program directors of the Joint Master Entrepreneurship (UvA/ VU), Bram Kuijken and Enno Masurel, has found that 17.8% of alumni have founded their own company and 11.0% are currently working freelance. Additionally, the study found that 41.9% of alumni is employed by a startup (19.7%) or a scale-up (22.2%). […]
NewsMedTech startup Sirius Medical has received CE Mark approval for Sirius Pintuition, a non-radioactive device to localize breast tumors. In 2016 Bram Schermers, then a scientist at NKI, pitched an early concept at the annual Amsterdam Science & Innovation Awards and won first prize! His pitch also caught the attention of seasoned entrepreneur Hubert Martens, […]
NewsDemonstrator Lab is an entrepreneurship laboratory, a learning-by-doing environment where students and staff of HvA, UvA, VU and Amsterdam UMC have the opportunity to test and transform ideas into tangible products or services. Demonstrator Lab is located at Vrije Universiteit Amsterdam and is part of the IXAnext valorization program. For those who have successfully started […]
NewsOver a short time period, the Coronavirus outbreak has profoundly affected the daily practice of Amsterdam UMC staff. Many promising initiatives have shown an enormous adaptive power, creativity and perseverance of the Amsterdam UMC personnel. Not only doctors, nurses and supporting staff have worked around the clock to provide the best care for patients, researchers […]
NewsThe IXAnext Physics2Market funding instrument, a seed funding to kick-start collaboration with industry on subjects in physics, is now also inviting initiatives contributing to the current COVID-19 pandemic. The Physics2Market grant not only provides funding on subjects in physics but also in the physical sciences in the broader sense. The maximum funding is € 35,000 […]
NewsUsing laser light techniques, UvA physicists and medical researchers have found that small cough droplets, potentially containing virus particles, can float in the air in a room for many minutes, especially when the room is poorly ventilated. Good ventilation in public spaces (e.g. public transport, nursing homes) is therefore crucial to slow down the spread […]
News